p.132 抽出テキスト

251. Liu L, Yang Y. Nutritional management mode of early cardiac rehabilitation in patients with Stanford type A aortic dissection. Comput Math Methods Med 2022;2022: 2124636. https://doi.org/10.1155/2022/2124636 252. Lauret GJ, Fokkenrood HJ, Bendermacher BL, Scheltinga MR, Teijink JA. Physical activity monitoring in patients with intermittent claudication. Eur J Vasc Endovasc Surg 2014; 47:656–63. https://doi.org/10.1016/j.ejvs.2014.03.001 253. Gardner AW, Addison O, Katzel LI, Montgomery PS, Prior SJ, Serra MC, et al. Association between physical activity and mortality in patients with claudication. Med Sci Sports Exerc 2021;53:732–9. https://doi.org/10.1249/mss.0000000000002526 254. Gardner AW, Montgomery PS, Parker DE. Physical activity is a predictor of all-cause mortality in patients with intermittent claudication. J Vasc Surg 2008;47:117–22. https:// doi.org/10.1016/j.jvs.2007.09.033 255. Gardner AW, Montgomery PS, Wang M, Shen B, Zhang S, Pomilla WA. Association between meeting physical activity time-intensity guidelines with ambulation, quality of life, and inflammation in claudication. J Cardiopulm Rehabil Prev 2022;42:E82–9. https://doi.org/10.1097/hcr.0000000000000686 256. Thijssen CGE, Bons LR, Gökalp AL, Van Kimmenade RRJ, Mokhles MM, Pelliccia A, et al. Exercise and sports participation in patients with thoracic aortic disease: a review. Expert Rev Cardiovasc Ther 2019;17:251–66. https://doi.org/10.1080/14779072.2019. 1585807 257. Delsart P, Maldonado-Kauffmann P, Bic M, Boudghene-Stambouli F, Sobocinski J, Juthier F, et al. Post aortic dissection: gap between activity recommendation and real life patients aerobic capacities. Int J Cardiol 2016;219:271–6. https://doi.org/10. 1016/j.ijcard.2016.06.026 258. Chaddha A, Eagle KA, Braverman AC, Kline-Rogers E, Hirsch AT, Brook R, et al. Exercise and physical activity for the post-aortic dissection patient: the clinician’s conundrum. Clin Cardiol 2015;38:647–51. https://doi.org/10.1002/clc.22481 259. Chaddha A, Kline-Rogers E, Woznicki EM, Brook R, Housholder-Hughes S, Braverman AC, et al. Cardiology patient page. Activity recommendations for postaortic dissection patients. Circulation 2014;130:e140–2. https://doi.org/10.1161/circulationaha.113. 005819 260. Katsiki N, Papadopoulou SK, Fachantidou AI, Mikhailidis DP. Smoking and vascular risk: are all forms of smoking harmful to all types of vascular disease? Public Health 2013; 127:435–41. https://doi.org/10.1016/j.puhe.2012.12.021 261. Wu CW, Chuang HY, Watanabe K, Wu P-S, Pan H-C, Wang C-L, et al. Association between secondhand smoke and peripheral arterial disease: a meta-analysis of crosssectional studies. Int Arch Occup Environ Health 2022;95:1091–101. https://doi.org/10. 1007/s00420-022-01837-9 262. Sode BF, Nordestgaard BG, Gronbaek M, Dahl M. Tobacco smoking and aortic aneurysm: two population-based studies. Int J Cardiol 2013;167:2271–7. https://doi.org/10. 1016/j.ijcard.2012.06.003 263. Altobelli E, Rapacchietta L, Profeta VF, Fagnano R. Risk factors for abdominal aortic aneurysm in population-based studies: a systematic review and meta-analysis. Int J Environ Res Public Health 2018;15:2805. https://doi.org/10.3390/ijerph15122805 264. Lederle FA, Nelson DB, Joseph AM. Smokers’ relative risk for aortic aneurysm compared with other smoking-related diseases: a systematic review. J Vasc Surg 2003;38: 329–34. https://doi.org/10.1016/s0741-5214(03)00136-8 265. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006;368:647–58. https://doi.org/10.1016/S0140-6736(06)69249-0 266. Mahtta D, Ramsey D, Krittanawong C, Al Rifai M, Khurram N, Samad Z, et al. Recreational substance use among patients with premature atherosclerotic cardiovascular disease. Heart 2021;107:650–6. https://doi.org/10.1136/heartjnl-2020-318119 267. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005;142:233–9. https://doi.org/10.7326/0003-4819-142- 4-200502150-00005 268. Suissa K, Lariviere J, Eisenberg MJ, Eberg M, Gore GC, Grad R, et al. Efficacy and safety of smoking cessation interventions in patients with cardiovascular disease: a network meta-analysis of randomized controlled trials. Circ Cardiovasc Qual Outcomes 2017;10: e002458. https://doi.org/10.1161/CIRCOUTCOMES.115.002458 269. Livingstone-Banks J, Fanshawe TR, Thomas KH, Theodoulou A, Hajizadeh A, Hartman L, et al. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2023;5:CD006103. https://doi.org/10.1002/14651858.CD006103.pub8 270. Rose JJ, Krishnan-Sarin S, Exil VJ, Hamburg NM, Fetterman JL, Ichinose F, et al. Cardiopulmonary impact of electronic cigarettes and vaping products: a scientific statement from the American Heart Association. Circulation 2023;148:703–28. https://doi.org/10.1161/CIR.0000000000001160 271. Lindson N, Butler AR, McRobbie H, Bullen C, Hajek P, Begh R, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev 2024;1:CD010216. https://doi. org/10.1002/14651858.CD010216.pub8 272. Travis N, Knoll M, Cadham CJ, Cook S, Warner KE, Fleischer NL, et al. Health effects of electronic cigarettes: an umbrella review and methodological considerations. Int J Environ Res Public Health 2022;19:9054. https://doi.org/10.3390/ijerph19159054 273. Abbott AJ, Reibel YG, Arnett MC, Marka N, Drake MA. Oral and systemic health implications of electronic cigarette usage as compared to conventional tobacco cigarettes: a review of the literature. J Dent Hyg 2023;97:21–35. 274. Hamann SL, Kungskulniti N, Charoenca N, Kasemsup V, Ruangkanchanasetr S, Jongkhajornpong P. Electronic cigarette harms: aggregate evidence shows damage to biological systems. Int J Environ Res Public Health 2023;20:6808. https://doi.org/10. 3390/ijerph20196808 275. Kavousi M, Pisinger C, Barthelemy JC, De Smedt D, Koskinas K, Marques-Vidal P, et al. Electronic cigarettes and health with special focus on cardiovascular effects: position paper of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol 2021;28:1552–66. https://doi.org/10.1177/2047487320941993 276. Goldman RE, Parker DR, Eaton CB, Borkan JM, Gramling R, Cover RT, et al. Patients’ perceptions of cholesterol, cardiovascular disease risk, and risk communication strategies. Ann Fam Med 2006;4:205–12. https://doi.org/10.1370/afm.534 277. Howarth M, Lister C. Social prescribing in cardiology: rediscovering the nature within us. Br J Card Nurs 2019;14:1–9. https://doi.org/10.12968/bjca.2019.0036 278. Nichols LO, Martindale-Adams J, Burns R, Graney MJ, Zuber J. Translation of a dementia caregiver support program in a health care system—REACH VA. Arch Intern Med 2011;171:353–9. https://doi.org/10.1001/archinternmed.2010.548 279. Martire LM, Schulz R, Keefe FJ, Rudy TE, Starz TW. Couple-oriented education and support intervention for osteoarthritis: effects on spouses’ support and responses to patient pain. Fam Syst Health 2008;26:185–95. https://doi.org/10.1037/1091-7527. 26.2.185 280. Morris SM, King C, Turner M, Payne S. Family carers providing support to a person dying in the home setting: a narrative literature review. Palliat Med 2015;29:487–95. https://doi.org/10.1177/0269216314565706 281. Ventura AD, Burney S, Brooker J, Fletcher J, Ricciardelli L. Home-based palliative care: a systematic literature review of the self-reported unmet needs of patients and carers. Palliat Med 2014;28:391–402. https://doi.org/10.1177/0269216313511141 282. Reynolds CF, III, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry 2022;21:336–63. https://doi.org/10.1002/wps.20996 283. Katch H. The role of self-efficacy in cardiovascular disease self-management: a review of effective programs. Patient Intelligence 2010;2:33–4. doi: https://doi.org/10.2147/PI. S12624] 284. Ohman EM, Bhatt DL, Steg PG, Goto S, Hirsch AT, Liau C-S, et al. The REduction of Atherothrombosis for Continued Health (REACH) registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events– study design. Am Heart J 2006;151:786.e1–10. https://doi.org/10.1016/j.ahj.2005.11. 004 285. Simons PC, Algra A, van de Laak MF, Grobbee DE, van der Graaf Y. Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol 1999;15: 773–81. https://doi.org/10.1023/a:1007621514757 286. Dorresteijn JA, Visseren FL, Wassink AM, Gondrie MJA, Steyerberg EW, Ridker PM, et al. Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score. Heart 2013;99:866–72. https://doi.org/10.1136/heartjnl-2013-303640 287. Kaasenbrood L, Bhatt DL, Dorresteijn JAN, Wilson PWF, D’Agostino RB, Massaro JM, et al. Estimated life expectancy without recurrent cardiovascular events in patients with vascular disease: the SMART-REACH model. J Am Heart Assoc 2018;7: e009217. https://doi.org/10.1161/JAHA.118.009217 288. Hageman SHJ, McKay AJ, Ueda P, Gunn LH, Jernberg T, Hagström E, et al. Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm. Eur Heart J 2022;43:1715–27. https://doi.org/10.1093/eurheartj/ehac056 289. van Trier TJ, Snaterse M, Boekholdt SM, Scholte Op Reimer WJM, Hageman SHJ, Visseren FLJ, et al. Validation of systematic coronary risk evaluation 2 (SCORE2) and SCORE2-older persons in the EPIC Norfolk prospective population cohort. Eur J Prev Cardiol 2024;31:182–9. https://doi.org/10.1093/eurjpc/zwad318 290. Wan D, Li V, Banfield L, Azab S, de Souza RJ, Anand SS, et al. Diet and nutrition in peripheral artery disease: a systematic review. Can J Cardiol 2022;38:672–80. https://doi. org/10.1016/j.cjca.2022.01.021 291. Sesso HD, Rist PM, Aragaki AK, Rautiainen S, Johnson LG, Friedenberg G, et al. Multivitamins in the prevention of cancer and cardiovascular disease: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial. Am J Clin Nutr 2022;115:1501–10. https://doi.org/10.1093/ajcn/nqac056 292. Bondonno NP, Murray K, Cassidy A, Bondonno CP, Lewis JR, Croft KD, et al. Higher habitual flavonoid intakes are associated with a lower risk of peripheral artery disease hospitalizations. Am J Clin Nutr 2021;113:187–99. https://doi.org/10.1093/ajcn/ nqaa300 293. Bapir M, Untracht GR, Cooke D, McVey JH, Skene SS, Campagnolo P, et al. Cocoa flavanol consumption improves lower extremity endothelial function in healthy individuals and people with type 2 diabetes. Food Funct 2022;13:10439–48. https://doi. org/10.1039/d2fo02017c 294. Fassora M, Calanca L, Jaques C, Mazzolai L, Kayser B, Lanzi S. Intensity-dependent effects of exercise therapy on walking performance and aerobic fitness in

ESC Guidelines                                                                                                                                                                                          3669

Downloaded from academic.oup.com/eurheartj/article/45/36/3538/7738955 by guest on 07 October 2026